NH-3
CAS No. 447415-26-1
NH-3( —— )
Catalog No. M28312 CAS No. 447415-26-1
NH-3 is an orally active, reversible thyroid hormone receptor (THR) antagonist with an IC 50 of 55 nM. NH-3, a derivative of the selective thyromi-metic GC-1, inhibits binding of thyroid hormones to their receptor and that inhibits cofactor recruitment.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 520 | Get Quote |
|
| 10MG | 750 | Get Quote |
|
| 25MG | 1143 | Get Quote |
|
| 50MG | 1521 | Get Quote |
|
| 100MG | 2061 | Get Quote |
|
| 500MG | 4158 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNH-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionNH-3 is an orally active, reversible thyroid hormone receptor (THR) antagonist with an IC 50 of 55 nM. NH-3, a derivative of the selective thyromi-metic GC-1, inhibits binding of thyroid hormones to their receptor and that inhibits cofactor recruitment.
-
DescriptionNH-3 is an orally active, reversible thyroid hormone receptor (THR) antagonist with an IC 50 of 55 nM. NH-3, a derivative of the selective thyromi-metic GC-1, inhibits binding of thyroid hormones to their receptor and that inhibits cofactor recruitment.(In Vivo):NH3 (46.2-27,700 nmol/kg/day; 7 days) decreases heart rate modestly starting at 46.2 nmol/kg/day, but the effect was lost at >2920 nmol/kg/day. NH3 has no effect on the cholesterol-lowering action of 46.2 nmol/kg/day T3, but it inhibits the tachycardic and TSH suppressant effects up to the 924 nmol/kg/day dose .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetTHR
-
RecptorNa+/Ca2+ Exchanger
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number447415-26-1
-
Formula Weight473.52
-
Molecular FormulaC28H27NO6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (211.18 mM)
-
SMILESCC(C)C1=CC(CC2=C(C)C=C(OCC(O)=O)C=C2C)=CC(C#CC2=CC=C(C=C2)[N+]([O-])=O)=C1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ohara F, et al. Preischemic and postischemic treatment with a new Na+/H+-exchange inhibitor, FR183998, shows cardioprotective effects in rats with cardiac ischemia and reperfusion. J Cardiovasc Pharmacol. 1999 Dec;34(6):848-56.
molnova catalog
related products
-
Liothyronine sodium
Liothyronine Sodium is the most potent form of thyroid hormone acting on the body to increase the basal metabolic rate, affect protein synthesis.
-
Liothyronine sodium ...
Liothyronine sodium hydrate (Triiodothyronine sodium hydrate) is a TRα and TRβ agonist and a thyroxine analog with anticancer and antitumor activities.
-
L-Thyroxine sodium s...
L-Thyroxine sodium salt pentahydrate?is a synthetic hormone for the research of hypothyroidism.?DIO enzymes convert biologically active thyroid hormone (Triiodothyronine,T3) from L-Thyroxine (T4).
Cart
sales@molnova.com